Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maple VC, officially known as The Maple Fund, is a seed-stage venture capital firm that focuses on investing in high-potential Canadian founders. While the firm is a generalist investor, it maintains a significant presence in the healthcare and life sciences sectors through strategic investments in health technology and biotechnology platforms. The fund's portfolio includes notable companies such as BenchSci, which utilizes artificial intelligence to accelerate biomedical research, and Dialogue, a leading virtual care platform. By providing early-stage capital and operational support, Maple VC aims to bridge the gap between Canadian innovation and global markets, particularly within the North American healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Maple Fund.